United States - Life Sciences, Biotechnology & Nanotechnology - FDA Provides Updates To Congress On FDORA, User Fee Implementation
FDA provided an update on the implementation of new accelerated approval authorities and emphasized that drugs approved under the pathway meet efficacy requirements.